Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now NasdaqCM - Nasdaq Real Time Price • USD Aspire Biopharma Holdings, Inc. (ASBPW) Follow Compare 0.0604 -0.0006 (-0.98%) At close: March 3 at 4:00:00 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement New product expected to set a new standard for potency and performance in the estimated $20 billon pre-workout market Desert Stream Inc., a well-established nutritional and supplement manufacturer of caffeine-based products, engaged for sourcing of ... Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is complete Test results support the next development step with Phase 1clinical trial expected to commence in April Provides Summary of Expected ... Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology (Nasdaq:ASBP)(Nasdaq:ASBPW), today announced ...